Image For Activity Cover
Journal Club: PARTNER 3 and Evolut Trials
Description

The continual stream of published science coupled with emphasis on practice improvement requirements has created a need for consensus building conversations that can guide practical practice change delivered at the point-of-care. However, finding the time to critically appraise the evidence or consider the practice implications has led the ACC to seek solutions not only for their members but all cardiovascular providers.

ACC’s educational program, ACC Journal Club offers opportunities to challenge emerging science, critique applicability to practice, consider practical point-of care solutions and cultivate future research opportunities that collective lead to improved cardiovascular health.

This activity is in response to the Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients (PARTNER 3) trial and the Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients (Evolut Low Risk Trial).

Author:
Brent C. Lampert, DO, FACC

Peer Reviewer:
Thomas M. Bashore, MD, FACC

Summary
Availability: On-Demand
Expires on Jul 11, 2022
Cost: FREE
Credit Offered:
2 CME Credits
2 ABIM-MOC Points
Android App Download IOS App Download Powered By